BioCentury
ARTICLE | Clinical News

Pirespa pirfenidone regulatory update

October 20, 2008 7:00 AM UTC

Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA from Shionogi for Pirespa pirfenidone to treat idiopathic pulmonary fibrosis (IPF). Shionogi has rights to the oral p38 mitogen-act...